Literature DB >> 12718487

Decreased contractility of the left ventricle is induced by the neurotransmitter acetylcholine, but not by vagal stimulation in rats.

Hisayuki Takahashi1, Kazuhira Maehara, Norio Onuki, Tomiyoshi Saito, Yukio Maruyama.   

Abstract

There is still controversy with respect to how an increase in vagal tone changes left ventricular (LV) contractility. It is possible that a difference in LV vagal innervation density may affect the inotropic effect. To test this, we examined the effects of vagal stimulation and acetylcholine (ACh) infusion on the rat ventricle, in which LV vagal innervation density is sparse and a negative force-frequency relationship is uniquely observed. To evaluate LV contractility, we developed an in situ Langendorff preparation, in which the effects of changes in afterload, preload, and coronary flow during an intervention were minimized. Both vagal stimulation and ACh infusion significantly increased LV systolic pressure (34 +/- 16%: 36 +/- 22%. respectively) and its maximum positive first derivative with slowing of heart rate (51 +/- 17%: 46 +/- 18%). These effects of vagal stimulation were abolished by pretreatment with atropine. During a fixed heart rate, LV systolic pressure was not changed by vagal stimulation, however, it was decreased slightly but significantly (11 +/- 8%) by ACh infusion. In conclusion, LV contractility changes due to ACh release during vagal stimulation were negligibly small, presumably due to a sparse vagal innervation density in rats, and therefore, a bradycardia-dependent indirect positive inotropic effect may be dominant compared to a direct negative inotropic action during vagal stimulation. Thus, the integrated effect of vagal nerve stimulation on LV contractility is different among species, because it is determined by a direct negative inotropic effect, which depends on the vagal innervation density in the left ventricle, as well as by bradycardia-dependent indirect inotropic changes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12718487     DOI: 10.1536/jhj.44.257

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  6 in total

1.  Device-based autonomic modulation in arrhythmia patients: the role of vagal nerve stimulation.

Authors:  William A Huang; Kalyanam Shivkumar; Marmar Vaseghi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-05

2.  Immunohistochemical characterization of the intrinsic cardiac neural plexus in whole-mount mouse heart preparations.

Authors:  Kristina Rysevaite; Inga Saburkina; Neringa Pauziene; Raimundas Vaitkevicius; Sami F Noujaim; José Jalife; Dainius H Pauza
Journal:  Heart Rhythm       Date:  2011-01-11       Impact factor: 6.343

3.  Direct evidence of nitric oxide release from neuronal nitric oxide synthase activation in the left ventricle as a result of cervical vagus nerve stimulation.

Authors:  Kieran E Brack; Vanlata H Patel; Rajkumar Mantravardi; John H Coote; G Andre Ng
Journal:  J Physiol       Date:  2009-04-29       Impact factor: 5.182

4.  Myocardial Infarction Causes Transient Cholinergic Transdifferentiation of Cardiac Sympathetic Nerves via gp130.

Authors:  Antoinette Olivas; Ryan T Gardner; Lianguo Wang; Crystal M Ripplinger; William R Woodward; Beth A Habecker
Journal:  J Neurosci       Date:  2016-01-13       Impact factor: 6.167

5.  Sudden Heart Rate Reduction Upon Optogenetic Release of Acetylcholine From Cardiac Parasympathetic Neurons in Perfused Hearts.

Authors:  Angel Moreno; Kendal Endicott; Matthew Skancke; Mary Kate Dwyer; Jaclyn Brennan; Igor R Efimov; Gregory Trachiotis; David Mendelowitz; Matthew W Kay
Journal:  Front Physiol       Date:  2019-01-28       Impact factor: 4.566

Review 6.  Molecular and cellular neurocardiology: development, and cellular and molecular adaptations to heart disease.

Authors:  Beth A Habecker; Mark E Anderson; Susan J Birren; Keiichi Fukuda; Neil Herring; Donald B Hoover; Hideaki Kanazawa; David J Paterson; Crystal M Ripplinger
Journal:  J Physiol       Date:  2016-06-17       Impact factor: 5.182

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.